Aurignac Finance is pleased to present its new Healthcare sector publication.
This new quarterly publication from our Healthcare practice was created with a simple objective: helping industrial groups, entrepreneurs and financial investors make better strategic decisions by providing an independent perspective on the trends shaping healthcare M&A.
Supported by a dedicated team and backed by Mergers Alliance’s international network of healthcare specialists, it combines sector expertise with cross-border execution capabilities across MedTech, Digital Health, Life Sciences, Healthcare Services and Pharma Services.
In addition to a selection of M&A and VC transactions completed across the healthcare sector in the first half of 2026, this first edition provides our market perspective – highlighting the resilience of healthcare M&A and the growing interest of international acquirers in European medtech and CDMOs – as well as a regulatory update on the MDR and a calendar of key upcoming industry events. It also includes the following focus areas:
- In-depth #1 – Service: medtech’s new growth engine on the path to the Smart OR
- In-depth #2 – Robotic surgery: cost democratization as the next growth driver
- In-depth #3 – M&A opportunities in medtech: a disconnection between valuations and fundamentals
- In-depth #4 – Medical devices: what is the FDA’s “breakthrough” label really worth?
- In-depth #5 – Digital Twins in Healthcare
- In-depth #6 – Gen AI goes mainstream, agentic AI is the next frontier
To receive the full version, send a mail to Alexandre Benoit at a.benoit@aurfi.com
